EVP, Chief Financial Officer
Tue, Mar 5, 2024
Mar 5
exercised or converted securities in TEVA
52,320 shares @ $0.00
Increased holdings by +25.20%
Net across this filing: -1.90% (-3,843 shares)
Option Exercise
Sale tied to a same-time option exercise
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—